Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
211M
-
Number of holders
-
125
-
Total 13F shares, excl. options
-
82.4M
-
Shares change
-
+640K
-
Total reported value, excl. options
-
$1.95B
-
Value change
-
+$16.7M
-
Put/Call ratio
-
3.82
-
Number of buys
-
67
-
Number of sells
-
-53
-
Price
-
$23.65
Significant Holders of INSMED Inc - Common Stock, par value $0.01 per share (INSM) as of Q2 2018
157 filings reported holding INSM - INSMED Inc - Common Stock, par value $0.01 per share as of Q2 2018.
INSMED Inc - Common Stock, par value $0.01 per share (INSM) has 125 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 82.4M shares
of 211M outstanding shares and own 39.09% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (12.5M shares), FMR LLC (11.5M shares), BlackRock Inc. (8.01M shares), JANUS HENDERSON GROUP PLC (7.45M shares), Palo Alto Investors LP (7.24M shares), VANGUARD GROUP INC (6.65M shares), STATE STREET CORP (2.98M shares), ORBIMED ADVISORS LLC (2.93M shares), Redmile Group, LLC (2.03M shares), and Foresite Capital Management IV, LLC (1.8M shares).
This table shows the top 125 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.